<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The EPICOLON consortium was initiated in 1999 by the Gastrointestinal <z:hpo ids='HP_0002664'>Oncology</z:hpo> Group of the Spanish Gastroenterology Association </plain></SENT>
<SENT sid="1" pm="."><plain>It recruited consecutive, unselected, population-based <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cases and control subjects matched by age and gender without personal or familial history of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:hpo ids='HP_0000001'>all</z:hpo> over Spain with the main goal of gaining knowledge in <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> and familial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>This epidemiological, prospective and multicentre study collected extensive clinical data and biological samples from âˆ¼2000 CRC cases and 2000 controls in Phases 1 and 2 involving 25 and 14 participating hospitals, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Genetic susceptibility projects in EPICOLON have included candidate-gene approaches evaluating single-nucleotide polymorphisms/genes from the historical category (linked to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk by previous studies), from human syntenic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> susceptibility regions identified in mouse, from the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>-related pathways Wnt and BMP, from regions 9q22 and 3q22 with positive linkage in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> families, and from the mucin gene family </plain></SENT>
<SENT sid="4" pm="."><plain>This consortium has also participated actively in the identification 5 of the 16 common, low-penetrance <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> genetic variants identified so far by genome-wide association studies </plain></SENT>
<SENT sid="5" pm="."><plain>Finishing their own pangenomic study and performing whole-exome sequencing in selected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples are among EPICOLON future research prospects </plain></SENT>
</text></document>